in Midrin with acetaminophen and dichloralphenazone at 65 mg. Midrin is no longer scripted in the U.S. because of risk of liver damage - Acetaminophen related, not Isomet related. The Tonix clinical trial is using 140 mg Isomet. Should be interesting results. From the patent:
. (R)-Isometheptene enantiomer or isomer 2 may be an anti-hypertensive agent with lower side effects than the racemate form. Therefore (R)-Isometheptene is believed to be effective against episodic tension-type headaches (ETTH). The (R)-Isometheptene enantiomer or isomer 2 is believed to effectively lower blood pressure, used alone or together with other headache ameliorating drugs.
This stock is getting to be a headache. Maybe we should be part of the phase III for (R)-Isometheptene.
This market is getting to be a headache. Strong buy at these price levels!